93 related articles for article (PubMed ID: 2479283)
21. Substance P in Solution: Trans-to-Cis Configurational Changes of Penultimate Prolines Initiate Non-enzymatic Peptide Bond Cleavages.
Conant CR; Fuller DR; El-Baba TJ; Zhang Z; Russell DH; Clemmer DE
J Am Soc Mass Spectrom; 2019 Jun; 30(6):919-931. PubMed ID: 30980380
[TBL] [Abstract][Full Text] [Related]
22. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture.
Bewsey KE; Wen C; Purple C; Homandberg GA
Biochim Biophys Acta; 1996 Oct; 1317(1):55-64. PubMed ID: 8876627
[TBL] [Abstract][Full Text] [Related]
23. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
Nagase H; Suzuki K; Morodomi T; Enghild JJ; Salvesen G
Matrix Suppl; 1992; 1():237-44. PubMed ID: 1480033
[TBL] [Abstract][Full Text] [Related]
24. Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli.
Matsas R; Fulcher IS; Kenny AJ; Turner AJ
Proc Natl Acad Sci U S A; 1983 May; 80(10):3111-5. PubMed ID: 6190172
[TBL] [Abstract][Full Text] [Related]
25. Comparison of native matrix metalloproteinases and their recombinant catalytic domains using a novel radiometric assay.
Brownell J; Earley W; Kunec E; Morgan BA; Olyslager B; Wahl RC; Houck DR
Arch Biochem Biophys; 1994 Oct; 314(1):120-5. PubMed ID: 7944383
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of substance P by granulation tissue-derived gelatinase.
Nakagawa H; Debuchi H
Biochem Pharmacol; 1992 Nov; 44(9):1773-7. PubMed ID: 1280434
[TBL] [Abstract][Full Text] [Related]
27. A continuous fluorimetric assay for tumor necrosis factor-alpha converting enzyme.
Jin G; Huang X; Black R; Wolfson M; Rauch C; McGregor H; Ellestad G; Cowling R
Anal Biochem; 2002 Mar; 302(2):269-75. PubMed ID: 11878807
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
Neumann U; Kubota H; Frei K; Ganu V; Leppert D
Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
[TBL] [Abstract][Full Text] [Related]
29. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
[TBL] [Abstract][Full Text] [Related]
30. Successive cleavage of N-terminal Arg1--Pro2 and Lys3-Pro4 from substance P but no release of Arg1-Pro2 from bradykinin, by X-Pro dipeptidyl-aminopeptidase.
Kato T; Nagatsu T; Fukasawa K; Harada M; Nagatsu I; Sakakibara S
Biochim Biophys Acta; 1978 Aug; 525(2):417-22. PubMed ID: 687639
[TBL] [Abstract][Full Text] [Related]
31. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
Itoh Y; Binner S; Nagase H
Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
[TBL] [Abstract][Full Text] [Related]
32. New fluorogenic substrates for N-arginine dibasic convertase.
Csuhai E; Juliano MA; Pyrek JS; Harms AC; Juliano L; Hersh LB
Anal Biochem; 1999 Apr; 269(1):149-54. PubMed ID: 10094786
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
[TBL] [Abstract][Full Text] [Related]
34. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin.
Mitchell TI; Jeffrey JJ; Palmiter RD; Brinckerhoff CE
Biochim Biophys Acta; 1993 Mar; 1156(3):245-54. PubMed ID: 8461313
[TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases.
Crabbe T; Willenbrock F; Eaton D; Hynds P; Carne AF; Murphy G; Docherty AJ
Biochemistry; 1992 Sep; 31(36):8500-7. PubMed ID: 1390635
[TBL] [Abstract][Full Text] [Related]
36. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.
Verheijen JH; Nieuwenbroek NM; Beekman B; Hanemaaijer R; Verspaget HW; Ronday HK; Bakker AH
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):603-9. PubMed ID: 9169591
[TBL] [Abstract][Full Text] [Related]
37. Purification and refolding of recombinant human proMMP-7 (pro-matrilysin) expressed in Escherichia coli and its characterization.
Itoh M; Masuda K; Ito Y; Akizawa T; Yoshioka M; Imai K; Okada Y; Sato H; Seiki M
J Biochem; 1996 Apr; 119(4):667-73. PubMed ID: 8743567
[TBL] [Abstract][Full Text] [Related]
38. The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate.
Okada Y; Harris ED; Nagase H
Biochem J; 1988 Sep; 254(3):731-41. PubMed ID: 3058116
[TBL] [Abstract][Full Text] [Related]
39. Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).
Arza B; De Maeyer M; Félez J; Collen D; Lijnen HR
Eur J Biochem; 2001 Feb; 268(3):826-31. PubMed ID: 11168424
[TBL] [Abstract][Full Text] [Related]
40. Qualitative and quantitative aspects of the degradation of several tripeptides derived from the antitumour peptide antagonist [Arg(6), D-Trp(7,9), MePhe(8)] substance P[6-11].
Reubsaet JL; Beijnen JH; Belshof EH; Bouyakhrichan M; Bult A; Hop E; Kellekule Y; van Maanen RJ; Teeuwsen J; Underberg WJ
J Pharm Biomed Anal; 1999 Mar; 19(3-4):277-84. PubMed ID: 10704092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
